Global Chromosomal Microarray Analysis (CMA) Testing Market Research Report 2024

Publication ID:

PB504242900

Publication Date:

April 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Chromosomal microarray analysis (CMA) is an emerging technology in the field of prenatal diagnosis. It can not only accurately detect whether the number of chromosomes and the structure of large fragments are abnormal,and it can detect microstructural variations such as microdeletions/microduplications,it has the advantages of high resolution, short detection cycle and objective results. However, CMA has certain limitations in the detection of balanced translocations, inversions, and low-level mosaicism.
The global Chromosomal Microarray Analysis (CMA) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chromosomal Microarray Analysis (CMA) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chromosomal Microarray Analysis (CMA) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Chromosomal Microarray Analysis (CMA) Testing in Medical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Chromosomal Microarray Analysis (CMA) Testing include Baylor Genetics, MedGenome Labs, Illumina Inc., CD Genomics, Thermo Fisher, Agilent, GeneDx, Quest Diagnostics and LabCorp, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chromosomal Microarray Analysis (CMA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chromosomal Microarray Analysis (CMA) Testing.
Report Scope
The Chromosomal Microarray Analysis (CMA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chromosomal Microarray Analysis (CMA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chromosomal Microarray Analysis (CMA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baylor Genetics
MedGenome Labs
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Centogene
Segment by Type
Single Nucleotide Polymorphism (SNP)
Comparative Genomic Hybridization (CGH)
Segment by Application
Medical
Laboratory
Clinical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chromosomal Microarray Analysis (CMA) Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single Nucleotide Polymorphism (SNP)
1.2.3 Comparative Genomic Hybridization (CGH)
1.3 Market by Application
1.3.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical
1.3.3 Laboratory
1.3.4 Clinical
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Perspective (2019-2030)
2.2 Chromosomal Microarray Analysis (CMA) Testing Growth Trends by Region
2.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Chromosomal Microarray Analysis (CMA) Testing Market Dynamics
2.3.1 Chromosomal Microarray Analysis (CMA) Testing Industry Trends
2.3.2 Chromosomal Microarray Analysis (CMA) Testing Market Drivers
2.3.3 Chromosomal Microarray Analysis (CMA) Testing Market Challenges
2.3.4 Chromosomal Microarray Analysis (CMA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chromosomal Microarray Analysis (CMA) Testing Players by Revenue
3.1.1 Global Top Chromosomal Microarray Analysis (CMA) Testing Players by Revenue (2019-2024)
3.1.2 Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chromosomal Microarray Analysis (CMA) Testing Revenue
3.4 Global Chromosomal Microarray Analysis (CMA) Testing Market Concentration Ratio
3.4.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chromosomal Microarray Analysis (CMA) Testing Revenue in 2023
3.5 Chromosomal Microarray Analysis (CMA) Testing Key Players Head office and Area Served
3.6 Key Players Chromosomal Microarray Analysis (CMA) Testing Product Solution and Service
3.7 Date of Enter into Chromosomal Microarray Analysis (CMA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chromosomal Microarray Analysis (CMA) Testing Breakdown Data by Type
4.1 Global Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Type (2025-2030)
5 Chromosomal Microarray Analysis (CMA) Testing Breakdown Data by Application
5.1 Global Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chromosomal Microarray Analysis (CMA) Testing Market Size (2019-2030)
6.2 North America Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2019-2024)
6.4 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size (2019-2030)
7.2 Europe Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2019-2024)
7.4 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size (2019-2030)
8.2 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size (2019-2030)
9.2 Latin America Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2019-2024)
9.4 Latin America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size (2019-2030)
10.2 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baylor Genetics
11.1.1 Baylor Genetics Company Detail
11.1.2 Baylor Genetics Business Overview
11.1.3 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Introduction
11.1.4 Baylor Genetics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.1.5 Baylor Genetics Recent Development
11.2 MedGenome Labs
11.2.1 MedGenome Labs Company Detail
11.2.2 MedGenome Labs Business Overview
11.2.3 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Introduction
11.2.4 MedGenome Labs Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.2.5 MedGenome Labs Recent Development
11.3 Illumina Inc.
11.3.1 Illumina Inc. Company Detail
11.3.2 Illumina Inc. Business Overview
11.3.3 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Introduction
11.3.4 Illumina Inc. Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.3.5 Illumina Inc. Recent Development
11.4 CD Genomics
11.4.1 CD Genomics Company Detail
11.4.2 CD Genomics Business Overview
11.4.3 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Introduction
11.4.4 CD Genomics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.4.5 CD Genomics Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Detail
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Introduction
11.5.4 Thermo Fisher Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.5.5 Thermo Fisher Recent Development
11.6 Agilent
11.6.1 Agilent Company Detail
11.6.2 Agilent Business Overview
11.6.3 Agilent Chromosomal Microarray Analysis (CMA) Testing Introduction
11.6.4 Agilent Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.6.5 Agilent Recent Development
11.7 GeneDx
11.7.1 GeneDx Company Detail
11.7.2 GeneDx Business Overview
11.7.3 GeneDx Chromosomal Microarray Analysis (CMA) Testing Introduction
11.7.4 GeneDx Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.7.5 GeneDx Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Detail
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Introduction
11.8.4 Quest Diagnostics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.8.5 Quest Diagnostics Recent Development
11.9 LabCorp
11.9.1 LabCorp Company Detail
11.9.2 LabCorp Business Overview
11.9.3 LabCorp Chromosomal Microarray Analysis (CMA) Testing Introduction
11.9.4 LabCorp Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.9.5 LabCorp Recent Development
11.10 Lineagen
11.10.1 Lineagen Company Detail
11.10.2 Lineagen Business Overview
11.10.3 Lineagen Chromosomal Microarray Analysis (CMA) Testing Introduction
11.10.4 Lineagen Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.10.5 Lineagen Recent Development
11.11 Invitae
11.11.1 Invitae Company Detail
11.11.2 Invitae Business Overview
11.11.3 Invitae Chromosomal Microarray Analysis (CMA) Testing Introduction
11.11.4 Invitae Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.11.5 Invitae Recent Development
11.12 Centogene
11.12.1 Centogene Company Detail
11.12.2 Centogene Business Overview
11.12.3 Centogene Chromosomal Microarray Analysis (CMA) Testing Introduction
11.12.4 Centogene Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2019-2024)
11.12.5 Centogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Baylor Genetics
MedGenome Labs
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Centogene

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂